Walden Group Healthcare M&A Blog

  • GE is Shrinking Even Further – Selling Its Biopharma Business to CEO’s Former Company

    04/23/2019
    General Electric is selling its biopharma business to Danaher Corp. for $21.4b. The deal complements Danaher's current biologics workflow solutions. GE’s biopharma business includes process chromatography hardware and consumables, cell culture media, single-use technologies, development instrumentation and consumables, and related services. GE...
    Read More
  • Rapid Growth for Gene Therapy

    04/23/2019
    Large pharmaceutical and diagnostic players companies have been acquiring emerging gene and cell therapy companies with promising drug pipelines or drug approvals, some with limited revenue. In March 2019, Thermo Fisher Scientific agreed to pay $1.7b to acquire Brammer Bio, which offers pre-clinical and analytical development, process...
    Read More
  • Catalent to Acquire Paragon Bioservices for $1.2b

    04/15/2019
    Catalent, Inc., a $2.46b provider of delivery technologies for drugs, biologics, and consumer and animal health products, is buying Paragon Bioservices, Inc., a developer of viral vectors for gene therapies. The deal Complements Catalent's biologics business. Paragon engages in the production and purification of therapeutic proteins, monoclonal...
    Read More
  • Smith & Nephew to Buy Osiris Therapeutics

    3/12/2019
    Smith & Nephew plc (LSE:SN, NYSE:SNN), a $4.9b maker of orthopedic, wound management, sports medicine and trauma & extremities products, is acquiring Osiris Therapeutics, Inc., a provider of regenerative medicine products, including skin, bone graft and articular cartilage substitutes. The deal accelerates S&N's wound management...
    Read More
  • Medtronic to Acquire EPIX Therapeutics

    1/25/2019
    Medtronic plc (NYSE: MDT), a $29.95b manufacturer of cardio-vascular, orthopedic, spinal and other medical devices., is buying EPIX Therapeutics, Inc. (formerly Advanced Cardiac Therapeutics), a maker of a catheter-based, temperature-controlled cardiac ablation systems. The acquisition expands Medtronic's cardiac ablation portfolio. EPIX...
    Read More
  • Page 2 of 1312345...10...Last »